GenOway
genOway is a biotechnology company with over 20 years of expertise in the development of physiologically relevant translational preclinical models. The company has developed a catalog of humanized, “off-the-shelf” cell and mouse models for immuno-oncology to accelerate research into the pathophysiology of cancer and enable the assessment of new therapeutic agents. Founded in 1999, genOway currently operates in more than 28 countries with 380 academic institutions and 170 life science companies, including 17 of the top 20 pharmaceutical companies.
